Literature DB >> 22814750

Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese.

Yun Huang1, Yufang Bi, Min Xu, Zhimin Ma, Yu Xu, Tiange Wang, Mian Li, Yu Liu, Jieli Lu, Yuhong Chen, Fei Huang, Baihui Xu, Jie Zhang, Weiqing Wang, Xiaoying Li, Guang Ning.   

Abstract

OBJECTIVE: To evaluate the associations between nonalcoholic fatty liver disease (NAFLD) and atherosclerosis. METHODS AND
RESULTS: A total of 8632 participants aged ≥ 40 years from Jiading district, Shanghai, were included in the present study. The presence of NAFLD was evaluated by ultrasonography. Carotid intima-media thickness (CIMT) and brachial-ankle pulse wave velocity (ba-PWV) were measured in each participant. The prevalence of NAFLD was 30.0% in the total population, with 30.3% in men and 29.9% in women, respectively. Subjects with NAFLD had remarkably higher CIMT and ba-PWV compared with those without NAFLD (0.594 ± 0.105 mm versus 0.578±0.109 mm, P<0.0001; 1665 ± 424 cm/s versus 1558 ± 430 cm/s, P<0.0001). Subjects with both NAFLD and metabolic syndrome had significantly higher CIMT and ba-PWV compared with those with neither or either of these 2 diseases after adjustment for age and sex (all P<0.05). Logistic regressions also revealed that NAFLD conferred 35% and 30% increased odds ratios of elevated CIMT and ba-PWV, independent of conventional risk factors and the presence of metabolic syndrome.
CONCLUSIONS: NAFLD was associated with elevated CIMT and ba-PWV, independent of conventional cardiovascular disease risk factors and metabolic syndrome. The effects of NAFLD and metabolic syndrome on atherosclerosis might not fully overlap.

Entities:  

Mesh:

Year:  2012        PMID: 22814750     DOI: 10.1161/ATVBAHA.112.252957

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  36 in total

1.  Serum lipoprotein (a) concentrations are inversely associated with T2D, prediabetes, and insulin resistance in a middle-aged and elderly Chinese population.

Authors:  Lin Ding; An Song; Meng Dai; Min Xu; Wanwan Sun; Baihui Xu; Jichao Sun; Tiange Wang; Yu Xu; Jieli Lu; Weiqing Wang; Yufang Bi; Guang Ning
Journal:  J Lipid Res       Date:  2015-02-03       Impact factor: 5.922

2.  CD8+ T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease.

Authors:  Denitra A Breuer; Maria Cristina Pacheco; M Kay Washington; Stephanie A Montgomery; Alyssa H Hasty; Arion J Kennedy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-11-11       Impact factor: 4.052

Review 3.  Nonalcoholic fatty liver disease and cardiovascular disease.

Authors:  Hong Liu; Hong-Yun Lu
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 4.  Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis.

Authors:  Luan Rodrigues Abdallah; Ricardo Cardoso de Matos; Yves Pacheco Dias March E Souza; Débora Vieira-Soares; Gabriela Muller-Machado; Priscila Pollo-Flores
Journal:  Curr Atheroscler Rep       Date:  2020-02-04       Impact factor: 5.113

5.  Association between sleep condition and arterial stiffness in Chinese adult with nonalcoholic fatty liver disease.

Authors:  Xia Cao; Jiansong Zhou; Hong Yuan; Zhiheng Chen
Journal:  J Thromb Thrombolysis       Date:  2016-07       Impact factor: 2.300

6.  Reduction of Some Atherogenic Indices in Patients with Non-Alcoholic Fatty Liver by Vitamin D and Calcium Co-Supplementation: A Double Blind Randomized Controlled Clinical Trial.

Authors:  Farzad Shidfar; Seyedeh Neda Mousavi; Hamid Lorvand Amiri; Shahram Agah; Sharieh Hoseini; Seyed Javad Hajimiresmail
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

Review 7.  Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis.

Authors:  Yang Jiao; Yan Lu; Xiao-ying Li
Journal:  Acta Pharmacol Sin       Date:  2014-12-15       Impact factor: 6.150

8.  No significant association between vitamin D and nonalcoholic fatty liver disease in a Chinese population.

Authors:  Lihua Li; Lei Zhang; Shaoyi Pan; Xinhua Wu; Xueyan Yin
Journal:  Dig Dis Sci       Date:  2013-04-16       Impact factor: 3.199

Review 9.  Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.

Authors:  Silvia Fargion; Marianna Porzio; Anna Ludovica Fracanzani
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

10.  Non-alcoholic fatty liver disease and risk of in-stent restenosis after bare metal stenting in native coronary arteries.

Authors:  Ke-Qing Shi; Fa-Ling Wu; Wen-Yue Liu; Chen-Chen Zhao; Chang-Xi Chen; Yao-Yao Xie; Sheng-Jie Wu; Xian-Feng Lin; Yong-Ping Chen; Danny Ka-Ho Wong; Man-Fung Yuen; Ming-Hua Zheng
Journal:  Mol Biol Rep       Date:  2014-04-02       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.